156 related articles for article (PubMed ID: 20021704)
1. Starch-entrapped microspheres show a beneficial fermentation profile and decrease in potentially harmful bacteria during in vitro fermentation in faecal microbiota obtained from patients with inflammatory bowel disease.
Rose DJ; Venema K; Keshavarzian A; Hamaker BR
Br J Nutr; 2010 May; 103(10):1514-24. PubMed ID: 20021704
[TBL] [Abstract][Full Text] [Related]
2. Starch-entrapped microspheres extend in vitro fecal fermentation, increase butyrate production, and influence microbiota pattern.
Rose DJ; Keshavarzian A; Patterson JA; Venkatachalam M; Gillevet P; Hamaker BR
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S121-30. PubMed ID: 18925612
[TBL] [Abstract][Full Text] [Related]
3. In vitro batch fecal fermentation comparison of gas and short-chain fatty acid production using "slowly fermentable" dietary fibers.
Kaur A; Rose DJ; Rumpagaporn P; Patterson JA; Hamaker BR
J Food Sci; 2011; 76(5):H137-42. PubMed ID: 22417432
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of the microbiota modulation abilities of different sized whole oat grain flakes.
Connolly ML; Lovegrove JA; Tuohy KM
Anaerobe; 2010 Oct; 16(5):483-8. PubMed ID: 20624475
[TBL] [Abstract][Full Text] [Related]
5. Effects of resistant starch type III polymorphs on human colon microbiota and short chain fatty acids in human gut models.
Lesmes U; Beards EJ; Gibson GR; Tuohy KM; Shimoni E
J Agric Food Chem; 2008 Jul; 56(13):5415-21. PubMed ID: 18543927
[TBL] [Abstract][Full Text] [Related]
6. Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats.
Koleva PT; Valcheva RS; Sun X; Gänzle MG; Dieleman LA
Br J Nutr; 2012 Nov; 108(9):1633-43. PubMed ID: 22243836
[TBL] [Abstract][Full Text] [Related]
7. Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial.
Rasmussen HE; Hamaker B; Rajan KB; Mutlu E; Green SJ; Brown M; Kaur A; Keshavarzian A
Nutr Res; 2017 Aug; 44():27-37. PubMed ID: 28821315
[TBL] [Abstract][Full Text] [Related]
8. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
[TBL] [Abstract][Full Text] [Related]
9. Prebiotics, synbiotics and inflammatory bowel disease.
Steed H; Macfarlane GT; Macfarlane S
Mol Nutr Food Res; 2008 Aug; 52(8):898-905. PubMed ID: 18383235
[TBL] [Abstract][Full Text] [Related]
10. In vitro fermentability of differently digested resistant starch preparations.
Fässler C; Arrigoni E; Venema K; Brouns F; Amadò R
Mol Nutr Food Res; 2006 Dec; 50(12):1220-8. PubMed ID: 17103375
[TBL] [Abstract][Full Text] [Related]
11. Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Nishikawa J; Kudo T; Sakata S; Benno Y; Sugiyama T
Scand J Gastroenterol; 2009; 44(2):180-6. PubMed ID: 18825588
[TBL] [Abstract][Full Text] [Related]
12. Dietary resistant and butyrylated starches have different effects on the faecal bacterial flora of azoxymethane-treated rats.
J Abell GC; Christophersen CT; McOrist AL; Clarke JM
Br J Nutr; 2011 May; 105(10):1480-5. PubMed ID: 21255474
[TBL] [Abstract][Full Text] [Related]
13. Small intestinal malabsorption and colonic fermentation of resistant starch and resistant peptides to short-chain fatty acids.
Nordgaard I; Mortensen PB; Langkilde AM
Nutrition; 1995; 11(2):129-37. PubMed ID: 7544175
[TBL] [Abstract][Full Text] [Related]
14. Two high-amylose maize starches with different amounts of resistant starch vary in their effects on fermentation, tissue and digesta mass accretion, and bacterial populations in the large bowel of pigs.
Bird AR; Vuaran M; Brown I; Topping DL
Br J Nutr; 2007 Jan; 97(1):134-44. PubMed ID: 17217569
[TBL] [Abstract][Full Text] [Related]
15. Starch Microspheres Entrapped with Chitosan Delay
Wang S; De Paepe K; Van de Wiele T; Fu X; Yuan Y; Zhang B; Huang Q
J Agric Food Chem; 2021 Oct; 69(41):12323-12332. PubMed ID: 34623811
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory bowel disease, gut bacteria and probiotic therapy.
Reiff C; Kelly D
Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
[TBL] [Abstract][Full Text] [Related]
17. Differential fermentation of glucose-based carbohydrates in vitro by human faecal bacteria--a study of pyrodextrinised starches from different sources.
Laurentin A; Edwards CA
Eur J Nutr; 2004 Jun; 43(3):183-9. PubMed ID: 15168041
[TBL] [Abstract][Full Text] [Related]
18. Panose, a new prebiotic candidate.
Mäkeläinen H; Hasselwander O; Rautonen N; Ouwehand AC
Lett Appl Microbiol; 2009 Dec; 49(6):666-72. PubMed ID: 19874483
[TBL] [Abstract][Full Text] [Related]
19. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
Aomatsu T; Imaeda H; Fujimoto T; Takahashi K; Yoden A; Tamai H; Fujiyama Y; Andoh A
Digestion; 2012; 86(2):129-35. PubMed ID: 22846404
[TBL] [Abstract][Full Text] [Related]
20. Bacterial flora in inflammatory bowel disease.
Marteau P
Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
